Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02111109
Other study ID # 14/YH/0078
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2014
Est. completion date June 13, 2017

Study information

Verified date September 2019
Source King's College Hospital NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Haemorrhage following major trauma is an important preventable cause of death. Those patients who survive may have a prolonged period of debility caused by failure of key body organs. We suspect that an important contributor to this organ failure may be dysfunction in the network of small blood vessels that supply the bodies organs with oxygen and nutrients. Our study will examine the link between the microcirculation and organ failure in patients who have suffered significant bleeding after traumatic injury. We will also explore the relationship between resuscitation of the global circulation (blood pressure, cardiac output etc.)an area that is monitored in clinical practice with the state of the microcirculation, which by contrast is not monitored. Patients with severe traumatic injury commonly have problems with blood clotting. Some researchers have suggested that microcirculatory failure may be an important contributor to this problem and we will explore this in more detail. Finally, we will attempt to examine some of the mechanisms by which the microcirculation may be disrupted by trauma and subsequent bleeding. These may include inappropriate activation of white blood cells, inadequate function of oxygen carrying red blood cells and changes to the cells lining the small blood vessels.

We will use a non invasive method to assess the microcirculation termed Side Stream Dark Field microscopy. This involves recorded a video image of the movement of blood within the small blood vessels under a patients tongue. In addition we will use ultrasound to assess the flow of blood from the heart. Small samples of blood will be taken to assess blood clotting and to look at possible mechanisms of microcirculatory dysfunction.

We aim to study ten patients in the first instance. The study will be carried out within the intensive care units at Kings College Hospital.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date June 13, 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria History of traumatic injury received blood products prior to ICU admission

Exclusion Criteria:

Not expected to survive 24 hours

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Side Stream Dark Field Microscopy


Locations

Country Name City State
United Kingdom University Hospital Birmingham Birmingham West Midlands
United Kingdom Kings College Hospital London
United Kingdom Royal London Hospital London

Sponsors (2)

Lead Sponsor Collaborator
King's College Hospital NHS Trust University Hospital Birmingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary SOFA score 72 hours
Secondary Length of ICU stay 28 days
Secondary Mortality 28 days